論文業績

  1. Nishiofuku H, Tanaka T, Fukuoka Y, Sato T, Masada T, Tatsumoto S, Sho M, Yamato I, Yasuda S, Matsushima S, Takano M, Ohbayashi C, Kichikawa K.
    Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model.
    J Vasc Interv Radiol. 2017 Mar;28(3):457-464.
  2. Sato T, Tanaka T, Nishiofuku H, Fukuoka Y, Sakaguchi H, Masada T, Tatsumoto S, Marugami N, Takano M, Yamato I, Sho M, Ohbayashi C, Hirai T, Kichikawa K.
    Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model.
    Cardiovasc Intervent Radiol. 2017 Mar;40(3):438-444.
  3. Hokuto D, Nomi T, Yasuda S, Kawaguchi C, Yoshikawa T, Ishioka K, Obara S, Yamada T, Kanehiro H.
    The safety of the early removal of prophylactic drainage after liver resection based solely on predetermined criteria: a propensity score analysis.
    HPB (Oxford). 2017 Apr;19(4):359-364.
  4. Yamaue H, Shimizu A, Hagiwara Y, Sho M, Yanagimoto H, Nakamori S, Ueno H, Ishii H, Kitano M, Sugimori K, Maguchi H, Ohkawa S, Imaoka H, Hashimoto D, Ueda K, Nebiki H, Nagakawa T, Isayama H, Yokota I, Ohashi Y, Shirasaka T.
    Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer.
    Cancer Chemother Pharmacol. 2017 Apr;79(4):813-823.
  5. Ito M, Migita K, Matsumoto S, Wakatsuki K, Tanaka T, Kunishige T, Nakade H, Nakatani M, Nakajima Y.
    Overexpression of E3 ubiquitin ligase tripartite motif 32 correlates with a poor prognosis in patients with gastric cancer.
    Oncol Lett. 2017 May;13(5):3131-3138.
  6. Portigliotti L, Fuks D, Slivca O, Bourdeaux C, Nomi T, Bennamoun M, Gentilli S, Gayet B.
    A comparison of laparoscopic resection of posterior segments with formal laparoscopic right hepatectomy for colorectal liver metastases: a single-institution study.
    Surg Endosc. 2017 Jun;31(6):2560-2565.
  7. Hokuto D, Nomi T, Yasuda S, Yoshikawa T, Ishioka K, Yamada T, Akahori T, Nakagawa K, Nagai M, Nakamura K, Obara S, Kanehiro H, Sho M.
    Long-term observation and treatment of a widespread intraductal papillary neoplasm of the bile duct extending from the intrapancreatic bile duct to the bilateral intrahepatic bile duct: A case report.
    Int J Surg Case Rep. 2017;38:166-171.
  8. Okada KI, Shimokawa T, Hirono S, Kawai M, Sho M, Satoi S, Matsumoto I, Eguchi H, Murakami Y, Yamada S, Doi M, Yamaue H; NAC-GA investigators.
    Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter Phase II Trial (NAC-GA Trial).
    Oncology. 2017;93(5):343-346.
  9. Yoshikawa T, Nomi T, Hokuto D, Yasuda S, Kawaguchi C, Yamada T, Kanehiro H, Nakajima Y.
    Risk Factors for Postoperative Ascites in Patients Undergoing Liver Resection for Hepatocellular Carcinoma.
    World J Surg. 2017 Aug;41(8):2095-2100.
  10. Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, Nakatani M, Kitano M, Sho M.
    Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer.
    World J Surg. 2017 Aug;41(8):2068-2077.
  11. Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Kitano M, Nakatani M, Kanehiro H.
    A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy.
    Surg Today. 2017 Aug;47(8):1018-1026.
  12. Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Kanehiro H.
    Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Dis Esophagus. 2017 Aug 1;30(8):1-7.
  13. Hokuto D, Nomi T, Kawaguchi C, Yoshikawa T, Yasuda S, Obara S, Yamato I, Yamada T, Kanehiro H, Nakajima Y.
    The Administration of Celecoxib as an Analgesic after Liver Resection Is Safe.
    Dig Surg. 2017;34(2):108-113.
  14. Satoi S, Yamamoto T, Yoshitomi H, Motoi F, Kawai M, Fujii T, Wada K, Arimitsu H, Sho M, Matsumoto I, Hirano S, Yanagimoto H, Ohtsuka M, Unno M, Yamaue H, Kon M.
    Developing better practices at the institutional level leads to better outcomes after pancreaticoduodenectomy in 3,378 patients: domestic audit of the Japanese Society of Pancreatic Surgery.
    J Hepatobiliary Pancreat Sci. 2017 Sep;24(9):501-510.
  15. Wakatsuki K, Matsumoto S, Migita K, Ito M, Kunishige T, Nakade H, Nakatani M, Kitano M, Takano M, Obayashi C, Sho M.
    Usefulness of computed tomography density of a tumor in predicting the response of advanced esophageal cancer to preoperative chemotherapy.
    Surgery. 2017 Oct;162(4):823-835.
  16. Kurata M, Honda G, Murakami Y, Uemura K, Satoi S, Motoi F, Sho M, Matsumoto I, Kawai M, Yanagimoto H, Fukumoto T, Nagai M, Gosho M, Unno M, Yamaue H; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS).
    Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor Size.
    World J Surg. 2017 Nov;41(11):2867-2875.
  17. Gupta R, Fuks D, Bourdeaux C, Radkani P, Nomi T, Lamer C, Gayet B.
    Impact of intraoperative blood loss on the short-term outcomes of laparoscopic liver resection.
    Surg Endosc. 2017 Nov;31(11):4451-4457.
  18. Kawai M, Hirono S, Okada KI, Satoi S, Yanagimoto H, Kon M, Murakami Y, Kondo N, Sho M, Akahori T, Toyama H, Fukumoto T, Fujii T, Matsumoto I, Eguchi H, Ikoma H, Takeda Y, Fujimoto J, Yamaue H.
    Reinforced staplers for distal pancreatectomy.
    Langenbecks Arch Surg. 2017 Dec;402(8):1197-1204.
  19. Miyagawa F, Sugano Y, Sho M, Asada H.
    TS-1 (tegafur/gimeracil/oteracil)-induced systemic lupus erythematosus with skin lesions and anti-Sm antibody.
    Eur J Dermatol. 2017 Dec 1;27(6):646-647.
  20. Jang JY, Park T, Lee S, Kim Y, Lee SY, Kim SW, Kim SC, Song KB, Yamamoto M, Hatori T, Hirono S, Satoi S, Fujii T, Hirano S, Hashimoto Y, Shimizu Y, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Han HS, Yoon YS, Sho M, Nagano H, Honda G, Kim SG, Yu HC, Chung JC, Nagakawa Y, Seo HI, Yamaue H.
    Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Ann Surg. 2017 Dec;266(6):1062-1068.